State Board of Administration of Florida Retirement System raised its stake in Qiagen NV (NYSE:QGEN) by 0.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 300,592 shares of the company’s stock after purchasing an additional 470 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Qiagen were worth $10,355,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in QGEN. Vanguard Group Inc raised its holdings in shares of Qiagen by 2.0% in the third quarter. Vanguard Group Inc now owns 6,627,163 shares of the company’s stock worth $251,037,000 after buying an additional 128,125 shares during the period. Morgan Stanley raised its holdings in shares of Qiagen by 16.3% in the third quarter. Morgan Stanley now owns 1,468,052 shares of the company’s stock worth $55,611,000 after buying an additional 205,698 shares during the period. State of Alaska Department of Revenue raised its holdings in shares of Qiagen by 2.0% in the fourth quarter. State of Alaska Department of Revenue now owns 23,547 shares of the company’s stock worth $811,000 after buying an additional 463 shares during the period. Quadrant Capital Group LLC raised its holdings in shares of Qiagen by 104.5% in the fourth quarter. Quadrant Capital Group LLC now owns 6,923 shares of the company’s stock worth $229,000 after buying an additional 3,538 shares during the period. Finally, Advisors Capital Management LLC purchased a new stake in shares of Qiagen in the fourth quarter worth approximately $272,000. Institutional investors own 62.35% of the company’s stock.

Shares of NYSE:QGEN opened at $36.68 on Tuesday. Qiagen NV has a 52-week low of $31.10 and a 52-week high of $39.45. The company has a market capitalization of $8.37 billion, a P/E ratio of 27.37, a PEG ratio of 2.27 and a beta of 0.89. The company has a current ratio of 2.22, a quick ratio of 2.05 and a debt-to-equity ratio of 0.63.

Qiagen (NYSE:QGEN) last announced its quarterly earnings data on Monday, February 4th. The company reported $0.40 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.40. Qiagen had a return on equity of 12.15% and a net margin of 12.68%. The company had revenue of $403.20 million for the quarter, compared to analysts’ expectations of $409.32 million. During the same quarter in the prior year, the firm earned $0.43 earnings per share. Qiagen’s revenue was up 1.6% compared to the same quarter last year. As a group, equities research analysts predict that Qiagen NV will post 1.46 earnings per share for the current fiscal year.

QGEN has been the topic of several research analyst reports. Barclays reissued a “buy” rating on shares of Qiagen in a research note on Tuesday, October 30th. Commerzbank reissued a “buy” rating on shares of Qiagen in a research note on Tuesday, October 30th. Deutsche Bank reissued a “buy” rating on shares of Qiagen in a research note on Tuesday, October 30th. Zacks Investment Research reissued a “hold” rating on shares of Qiagen in a research note on Wednesday, November 14th. Finally, BidaskClub raised Qiagen from a “sell” rating to a “hold” rating in a research note on Friday, November 2nd. Seven research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $41.00.

COPYRIGHT VIOLATION WARNING: “Qiagen NV (QGEN) Shares Bought by State Board of Administration of Florida Retirement System” was published by Daily Political and is owned by of Daily Political. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dailypolitical.com/2019/02/12/qiagen-nv-qgen-shares-bought-by-state-board-of-administration-of-florida-retirement-system.html.

About Qiagen

QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, target enrichment, and library preparation for sequencing applications; and assay technology solutions.

Read More: Market Capitalization in the Stock Market

Want to see what other hedge funds are holding QGEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Qiagen NV (NYSE:QGEN).

Institutional Ownership by Quarter for Qiagen (NYSE:QGEN)

Receive News & Ratings for Qiagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen and related companies with MarketBeat.com's FREE daily email newsletter.